Ambulatory Toxicity Management (AToM) in patients receiving adjuvant or neo-adjuvant chemotherapy for early stage breast cancer - a pragmatic cluster randomized trial protocol

Ambulatory Toxicity Management (AToM) in patients receiving adjuvant or neo-adjuvant chemotherapy for early stage breast cancer - a pragmatic cluster randomized trial protocol

Abstract Background Population-based studies suggest that emergency department visits and hospitalizations are common among patients receiving chemotherapy and that rates in routine practice are higher than expected from clinical trials. Chemotherapy-related toxicities are often predictable and, con...

Full description

Bibliographic Details
Main Authors: Monika K. Krzyzanowska, Jim A. Julian, Melanie Powis, Doris Howell, Craig C. Earle, Katherine A. Enright, Nicole Mittmann, Maureen E. Trudeau, Eva Grunfeld
Format: Article
Language:English
Published: BMC 2019-09-01
Series:BMC Cancer
Subjects:
Breast cancer
Symptom management
Chemotherapy toxicity
Telephone case management
Quality improvement
Online Access:http://link.springer.com/article/10.1186/s12885-019-6099-x

Internet

http://link.springer.com/article/10.1186/s12885-019-6099-x

Similar Items